CFPA Home Page
QuickJump
 
               
Browse By Industry
Clinical/Non-Clinical
  

Browse the Clinical/Non-Clinical courses below or visit our GCP Training or GLP Training pages.


Course TitleScheduled
A Risk Based Approach to Computer Systems Validation
An Introduction to Orphan Drug Submissions and Application
An Introduction to Pathways for Skin Penetration
Auditing and Inspecting Clinical Research in the Global Environment 
Auditing and Inspecting Preclinical Research for GLP Compliance 
Basic Requirement of the Bacterial Endotoxin Testing (BET) or LAL Program
Best Practices in SAS Statistical Programming for Regulatory Submission 
Best Practices in SAS Statistical Programming for Regulatory Submission: Creating Publication-Quality Summary Tables (SECOND in a Two-Part Series)
Biosafety of Biological Drug Products 
Biostatistics for the Non-Statistician - Beyond the Basics 
Characterization of Proteins: Isolation & Analysis 
Claim Substantiation for Clinical Studies of Cosmetic Products
Claim Substantiation for Clinical Studies of Cosmetic Products/Online
Clinical Testing Submissions
Cloud Computing in the Pharmaceutical Industry: Paradigm Shift in Project Management, Analysis and Validation 
CMC Writing and Submission Strategies: A Global Regulatory Approach
Combination Product Development: Safety/Registration/Approval 
Computerized Systems Used in Clinical Investigations: the New FDA Guidance
Conducting Effective Quality Audits
Crackdown on Institutional Review Boards (IRBs) 
Delivery Systems in Personal Care
Developing Specifications for Drug Substances and Drug Products
Early Stage Clinical Studies for Drugs and Devices 
Effective Clinical Data Acceptance Testing
Effective Tools in Selecting a CRO 
Effectively Managing CROs
Effects of Psychological Factors and Stress on Skin Inflammatory Disorders
Electronic Records: 21 CFR Part 11-Revisited
Endotoxin Testing: Resolving Interference and Test Validation
Equipment Qualification 1.0
Essential Oils in Skin Product Formulation
Ethnic Skins and Skin-of-Color: Biological and Product Development Differences
Fundamentals of Biochemistry: Background for Biotechnology 
Gene Expression Studies for Skin Product Development: An Introduction to the Basics
Gene Expression Studies for Skin Product Development: Basics & Beyond 
GLP Study Director
Good Clinical Practices (GCP) 
Good Laboratory Practices (GLP)
Guidelines for Skin Absorption Studies 
Guidelines to In Vitro Skin Absorption Studies
INDs/NDAs/CTDs
Introduction to Drug Delivery Technology 
IQ, OQ, PQ
Measurement Uncertainty in Analytical Chemistry 
Meeting Today’s FDA Requirements for Clinical Trial Processes
Monitoring of Clinical Drug Studies 
Non-Clinical Drug Safety Evaluation and Drug Development
Orphan Drug Application and Submission 
Outsourcing Pharmaceutical Operations 
Overcoming the Challenges to Transdermal Drug Delivery Development–An Introduction
Pharmacokinetics—ADME Fundamentals
Practical Biostatistics for the Non-Statistician - The Basics 
Preparation, Packaging and Labeling of Clinical Trial Materials
Principles of Contemporary Immunology 
Protein Characterization Essentials
QbD Beyond Concepts: A Practical Implementation Plan
Qualification and Validation of Analytical Methods for Protein Products 
Qualification/Validation for Bacterial Endotoxin Testing (BET)
Safety Assessment and Biocompatibility Evaluation
Safety Assessment of Cosmetic Ingredients and Formulations: The Basics
Selecting and Managing CROs
Skin Biochemistry Basics (First in a 3-Part Series)
Skin Biochemistry Basics (Second in a 3-Part Series)
Skin Biochemistry Basics (Third in a 3-Part Series)
Skin Lightening Product Development: From Biochemistry to Applications
Skin Product Adverse Effects: Causes and Prevention
Skin Toxicology-Part 1: Introduction to Skin Toxicology
Skin Toxicology-Part 10: Testing for Eye Irritation and Corrosion
Skin Toxicology-Part 11: Testing for Toxicity to Reproduction and Endocrine Disruption
Skin Toxicology-Part 12: Testing for Skin Adverse Effects Through Biomarkers Analysis
Skin Toxicology-Part 2: Alternative Methods for Skin Safety Assessment
Skin Toxicology-Part 3: Cytotoxicity Testing
Skin Toxicology-Part 4: Testing for Skin Irritation–Basics and Alternatives
Skin Toxicology-Part 5: Skin Sensitization Basics and Newest Testing Methods
Skin Toxicology-Part 6: Testing for Photo-toxicity
Skin Toxicology-Part 7: Testing for Genotoxicity
Skin Toxicology-Part 8: Guidelines to In Vitro Skin Absorption Studies
Skin Toxicology-Part 9: Testing for Toxicokinetics and Skin Metabolism
Strategies for 21 CFR Part 11 Cost Effective Compliance Using a Risk-based Approach
Testing for Acute Chemical Toxicity – In Vitro Approaches Compliance with REACH and the 7th Amendment 
Testing for Cytotoxicity-Compliance with REACH and the 7th Amendment
Testing for Eye Irritation and Corrosion: Compliance with REACH and the 7th Amendment
Testing for Genotoxicity, Mutagenicity and Carcinogenicity: Compliance with REACH and the 7th Amendment
Testing for Toxicity to Reproduction and Endocrine Disruption – Compliance with REACH and the 7th Amendment 
The China Syndrome: Quality Issues in Manufacturing
The Harmful Effects of Visible Light to Skin: Gene Expression Insights
The Use of Naturals in Skin Product Development: Focus on Ayurveda and Chinese Herbs
Toxicokinetics and Skin Metabolism Testing: Compliance with REACH and the 7th Amendment
Writing and Implementing Clinical Protocols